Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The cystatin superfamily encompasses proteins that contain multiple cystatin-like sequences. Additionally we are shipping Cystatin C Kits (121) and Cystatin C Proteins (74) and many more products for this protein.
Showing 10 out of 463 products:
Human Monoclonal CST3 Primary Antibody for ELISA, WB - ABIN1045447
Shlipak, Katz, Kestenbaum, Fried, Newman, Siscovick, Stevens, Sarnak: Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C. in American journal of nephrology 2009
Show all 17 Pubmed References
Human Monoclonal CST3 Primary Antibody for ELISA, WB - ABIN965940
Helisalmi, Väkevä, Hiltunen, Soininen: Flanking markers of cystatin c (CST3) gene do not show association with Alzheimer's disease. in Dementia and geriatric cognitive disorders 2009
Show all 2 Pubmed References
Human Monoclonal CST3 Primary Antibody for ELISA, WB - ABIN969070
Rehman, Fought, Solomon: N-acetylcysteine effect on serum creatinine and cystatin C levels in CKD patients. in Clinical journal of the American Society of Nephrology : CJASN 2008
Show all 2 Pubmed References
Human Polyclonal CST3 Primary Antibody for ELISA, WB - ABIN439722
Mi, Pawlik, Sastre, Jung, Radvinsky, Klein, Sommer, Schmidt, Nixon, Mathews, Levy: Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models. in Nature genetics 2007
Mouse (Murine) Polyclonal CST3 Primary Antibody for ELISA, WB - ABIN249523
Huh, Nagle, Kozak, Abrahamson, Karlsson: Structural organization, expression and chromosomal mapping of the mouse cystatin-C-encoding gene (Cst3). in Gene 1995
Human Monoclonal CST3 Primary Antibody for IHC, IHC (p) - ABIN4301883
Gren, Janciauskiene, Sandeep, Jonigk, Kvist, Gerwien, Håkansson, Grip: The protease inhibitor cystatin C down-regulates the release of IL-β and TNF-α in lipopolysaccharide activated monocytes. in Journal of leukocyte biology 2016
Human Monoclonal CST3 Primary Antibody for ELISA - ABIN2473151
Young, Kandarian, Kurowski: Skeletal muscle glucose uptake following overload-induced hypertrophy. in Life sciences 1992
Show all 2 Pubmed References
Human Monoclonal CST3 Primary Antibody for IA, ELISA - ABIN2473150
Mussap, Plebani: Biochemistry and clinical role of human cystatin C. in Critical reviews in clinical laboratory sciences 2004
Human Polyclonal CST3 Primary Antibody for IHC, IHC (p) - ABIN4301882
Wu, Hsu, Chen, Yu, Chang, Tai, Liu, Su, Chang, Yu: Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas. in Molecular & cellular proteomics : MCP 2010
There were no associations between serum cysC levels and renal involvement in patients with primary Sjogren's syndrome.
cystatin-C should be considered an early biomarker of AKI
CysC is as an early acute kidney injury biomarker and predictive of persistent acute kidney injury on aminoglycoside treatment.
Cystatin C may be considered a biological marker for vascular dysfunction and subclinical atherosclerosis in SCD (show SCD Antibodies).
Serum cystatin C level was significantly associated with subclinical atherosclerosis. An increase in cystatin C level could be a valuable surrogate marker for the risk of cardiovascular disease in patients with type 2 diabetes mellitus.
Mild-to-moderate kidney dysfunction modifies the relationship between CysC and high-risk coronary lesion, but not NGAL (show LCN2 Antibodies).
Increasing cystatin C and cathepsin B (show CTSB Antibodies) reported in serum of colorectal cancer patients.
Both cystatin C and beta 2 macroglobulin are elevated in type 2 diabetics with diabetic nephropathy. Cystatin C may be useful in the early diagnosis of diabetic nephropathy
Results from nuclear magnetic resonance structural data and molecular dynamics modeling point to conformational requirements and special importance of some amino acid residues in cystatin 3 C-terminal for the its interaction with amyloid beta fragments.
The findings of the current studies may be important for future design of hCC (show FAM126A Antibodies) dimerization inhibitors.
CysC plays an important regulatory role in combating cell death via the autophagic pathway in atherosclerosis.
Data (including data from studies in mutant mice) suggest that up-regulation of Cst3, as observed in plasma of mice with type 2 diabetes, down-regulates insulin (show INS Antibodies) signaling and promotes endoplasmic reticulum stress in hepatocytes but not in myotubes.
Cystatin C is a potential pathogenic signal triggering neurodegeneration in multiple system atrophy.
The neuroprotective activity of CysC against Amyotrophic lateral sclerosis-linked mutant Cu/Zn-superoxide dismutase (SOD1 (show SOD1 Antibodies))-mediated toxicity.
an important role for macrophages, DC, and ROS (show ROS1 Antibodies) in diseases associated with the protease inhibitory activity or amyloidogenic properties of cystatin C.
APP (show APP Antibodies) expression stimulates NSPC proliferation; this effect is mediated via an increase in cystatin C secretion
Cystatin C, a protein targeted to the classical secretory pathway by its signal peptide sequence, is secreted by primary neurons in at least 9 different cystatin C glycoforms associated with exosomes.
The lack of cystatin C enhances Collagen-induced arthritis and primarily affects in vivo priming of the immune system
Inflammation causes downregulation of cystatin C expression in dendritic cells and reduces serum CstC levels.
Data show that the absence of cystatin C reduced epithelial cell apoptosis but increased proliferation in skin.
CST3 may be required to remodel endometrial and placental tissues for close apposition between maternal and fetal vasculatures and to facilitate transplacental transport of gases, micronutrients (amino acids, glucose), and macromolecules (proteins).
Increased production of cystatin C in osteoarthritis synovium does not alleviate synovitis or cartilage pathology.
Cystatin C in milk basic protein (MBP (show MBP Antibodies)) is suggested as one of the factors inhibiting bone resorption
The cystatin superfamily encompasses proteins that contain multiple cystatin-like sequences. Some of the members are active cysteine protease inhibitors, while others have lost or perhaps never acquired this inhibitory activity. There are three inhibitory families in the superfamily, including the type 1 cystatins (stefins), type 2 cystatins and the kininogens. The type 2 cystatin proteins are a class of cysteine proteinase inhibitors found in a variety of human fluids and secretions, where they appear to provide protective functions. The cystatin locus on chromosome 20 contains the majority of the type 2 cystatin genes and pseudogenes. This gene is located in the cystatin locus and encodes the most abundant extracellular inhibitor of cysteine proteases, which is found in high concentrations in biological fluids and is expressed in virtually all organs of the body. A mutation in this gene has been associated with amyloid angiopathy. Expression of this protein in vascular wall smooth muscle cells is severely reduced in both atherosclerotic and aneurysmal aortic lesions, establishing its role in vascular disease.
, egg-white cystatin
, cystatin C
, cystatin 3
, hypothetical protein
, bA218C14.4 (cystatin C)
, neuroendocrine basic polypeptide
, Cystatin C (cysteine proteinase inhibitor)
, colostrum thiol proteinase inhibitor
, cystatin C (amyloid angiopathy and cerebral hemorrhage)